首页> 外文期刊>Advances in anatomic pathology >Disclosure of Harmful Medical Error to Patients: A Review With Recommendations for Pathologists
【24h】

Disclosure of Harmful Medical Error to Patients: A Review With Recommendations for Pathologists

机译:披露对患者有害医疗误差:审查病理学家的建议

获取原文
获取原文并翻译 | 示例
           

摘要

Harmful error is an infrequent but serious challenge in the pathology laboratory. Regulatory bodies and advocacy groups have mandated and encouraged disclosure of error to patients. Many pathologists are interested in participating in disclosure of harmful error but are ill-equipped to do so. This review of the literature with recommendations examines the current state of the patient safety movement and error disclosure as it pertains to pathology and provides a practical and explicit guide for pathologists for who, when, and how to disclose harmful pathology error to patients. The authors provide a definition of harmful pathology error, and the rationale and principles behind effective disclosure are discussed. The changing culture of medicine and its effect on pathology is examined including the trend towards increasing transparency and patient engagement. Related topics are addressed including the management of expected adverse events, barriers to disclosure, and additional resources for the implementation of disclosure programs in pathology.
机译:有害错误是病理学实验室的一个不常见但严重的挑战。监管机构和宣传群体已授权并鼓励患者披露误差。许多病理学家有兴趣参与有害错误的披露,而是可以妥善自名一意。对文献的审查提出了建议,研究了患者安全运动的当前状态和错误披露,因为它涉及病理学,为患者披露有害病理学误差,为患者披露有害病理学误差,为病理学家提供了实用和明确的指南。作者提供了有害病理学误差的定义,讨论了有效披露背后的理由和原则。研究了药物不断变化的文化及其对病理学的影响,包括提高透明度和患者参与的趋势。有关的主题,包括管理预期不利事件,披露障碍,以及在病理学中实施披露方案的额外资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号